Kalium-Natrium-Glukose Sad

Potassium chloride, sodium chloride and glucose monohydrate, the active ingredient in Kalium-Natrium-Glukose Sad, is an electrolyte solution presented as a solution for injection for intravenous use. It helps correct electrolyte and fluid deficits in patients requiring electrolyte replacement, such as those with hypokalemia, hyponatremia, or hypoglycemia.

GNH USA supplies Kalium-Natrium-Glukose Sad as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kalium-Natrium-Glukose Sad is used in clinical situations that require rapid correction of electrolyte and fluid imbalances. - Electrolyte replacement: restores potassium and sodium levels in patients with deficits. - Fluid therapy: provides necessary volume and glucose for patients needing intravenous fluid support. - Hypokalemia: corrects low potassium concentrations in the blood. - Hyponatremia: raises sodium concentration to normal range. - Hypoglycemia: supplies glucose to raise blood sugar levels.

Adverse reactions may occur with any intravenous electrolyte solution.

Common Side Effects: - Injection site irritation: redness or pain at the infusion site. - Hyperkalemia: elevated serum potassium levels. - Hypernatremia: elevated serum sodium levels. - Hyperglycemia: increased blood glucose concentration. - Phlebitis: inflammation of the vein used for infusion. - Electrolyte imbalance: transient shifts in other electrolytes.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte disturbances. - Severe hyperkalemia: can lead to life‑threatening cardiac events. - Anaphylactic reaction: rare severe allergic response. - Fluid overload: excessive volume leading to pulmonary edema. - Severe hyperglycemia: may precipitate diabetic complications. - Metabolic acidosis: rare disturbance of acid‑base balance.

Careful assessment and monitoring are required when using this intravenous solution. - Assess electrolyte levels: measure serum potassium, sodium, and glucose before administration. - Adjust infusion rate: tailor to the patient’s clinical status to avoid rapid shifts. - Monitor cardiac function: observe ECG for arrhythmias during therapy. - Use compatible IV solutions: avoid mixing with drugs that may precipitate. - Avoid in patients with severe renal failure: risk of electrolyte accumulation. - Store at ambient temperature: keep in original container, protect from light and moisture.

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - ACE inhibitors: may increase serum potassium and risk of hyperkalemia. - Potassium‑sparing diuretics: additive effect on potassium levels. - Hypertonic glucose solutions: can cause severe hyperglycemia when combined. - IV calcium chloride: risk of precipitation with phosphate‑containing solutions. - Sodium bicarbonate: may cause rapid shifts in serum sodium.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal function, affecting electrolyte clearance. - Insulin: enhances cellular uptake of potassium and glucose, requiring dose adjustments. - Beta‑blockers: can mask symptoms of hypoglycemia. - Loop diuretics: increase sodium loss, necessitating careful monitoring. - IV contrast agents: may affect renal handling of electrolytes.